Blue Water Life Science Advisors, LP Natera, Inc. Transaction History
Blue Water Life Science Advisors, LP
- $106 Million
- Q1 2024
A detailed history of Blue Water Life Science Advisors, LP transactions in Natera, Inc. stock. As of the latest transaction made, Blue Water Life Science Advisors, LP holds 503,094 shares of NTRA stock, worth $53.6 Million. This represents 43.28% of its overall portfolio holdings.
Number of Shares
503,094
Previous 397,436
26.58%
Holding current value
$53.6 Million
Previous $24.9 Million
84.82%
% of portfolio
43.28%
Previous 21.81%
Shares
12 transactions
Others Institutions Holding NTRA
# of Institutions
439Shares Held
117MCall Options Held
254KPut Options Held
263K-
Vanguard Group Inc Valley Forge, PA11MShares$1.18 Billion0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY7.36MShares$784 Million0.06% of portfolio
-
Fred Alger Management, LLC New York, NY6.55MShares$697 Million3.03% of portfolio
-
Black Rock Inc. New York, NY6.49MShares$691 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.93MShares$418 Million1.68% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $10.3B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...